© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Atlas Genetics Completes $20m Series C Fundraising
Posted 27th February 2015

Atlas Genetics Completes $20m Series C Fundraising

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Atlas Genetics Completes $20m Series C Fundraising
Image

Atlas Genetics Completes $20m Series C Fundraising

Atlas Genetics Ltd (“Atlas” or the “Company”), the ultra-rapid ‘test and treat’ molecular diagnostics company, announced the completion of a Series C financing, raising $20 million from a syndicate including existing investors and one new investor, RMI Partners.

New investor, RMI Partners, is a global life sciences venture capital firm, the largest in Eastern Europe. Existing investors include Novartis Venture Funds, Consort Medical plc, Johnson & Johnson Innovation – JJDC, Inc., LSP, BB Biotech Ventures and South West Ventures Fund. This newly announced financing follows on from the previously announced Series B fundraising of $25 million.

Atlas develops ultra-rapid point-of-care diagnostic tests for infectious diseases. The io® system is at an advanced stage of development and is expected to be launched in Europe with the first test for Chlamydia later this year. The Series C investment will be used to accelerate the launch of the io® system, initiate US clinical trials, and expand the menu of tests available initially in the STI (sexually transmitted infections) and HAI (hospital acquired infections) markets.

Dr John Clarkson, Chief Executive Officer of Atlas, commented: “We would like to thank our investors for their continued support and we are delighted to welcome RMI Partners to the syndicate. This is an exciting time for the Company as we prepare our first product, a test for the sexually transmitted infection Chlamydia, for launch in Europe later this year. The funds raised will enable us to commercialise our io® system and to build out a programme of much needed ‘test and treat’ assays in markets where time really does matter, both for the physician and for the patient.”

For more information about Atlas Genetics, please visit atlasgenetics.com.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
What Are the Best Cryptocurrencies to Invest In?
Finance
16/11/2021What Are the Best Cryptocurrencies to Invest In?

Which will be the best Cryptocurrency to invest in 2021? The answer will come from a careful assessment of each distinct asset and its suitability for investing in the global marketplace.

Read Full PostRead - Eye Icon
What is a Vendor Manager and Why Would You Want One For Your Business
News
04/07/2022What is a Vendor Manager and Why Would You Want One For Your Business

Vendors are often at the heart of an organization's operations and activities. They accelerate the growth of your company, help achieve profit goals and generate sizable revenue.

Read Full PostRead - Eye Icon
EU Consumer Scoreboard Shows Untapped E-Commerce Potential
Finance
28/09/2015EU Consumer Scoreboard Shows Untapped E-Commerce Potential

The 2015 EU Consumer Scoreboard shows that cross-border e-commerce is still an under-developed market in Europe, and 61% of consumers feel more confident buying online from their own country (61%) than from another EU country (38%).

Read Full PostRead - Eye Icon
Bulge Bracket Banks Increased their M&A Advisory Market Share in 2015’s Record-Breaking Merger Spree
Finance
02/03/2016Bulge Bracket Banks Increased their M&A Advisory Market Share in 2015’s Record-Breaking Merger Spree

The largest investment banks notched a 20% gain in market share of the US M&A advisory market during last-year’s record-breaking technology M&A spree, according to a new report by 451 Research.

Read Full PostRead - Eye Icon
4 Tips For Automating Your Business Security Successfully
Innovation
08/09/20224 Tips For Automating Your Business Security Successfully

According to Statistica, 47.3% of companies are embracing automation from a security perspective. If you’re looking to automate your business’ security successfully, you need an awareness of the tools and technologies most beneficial for security automatio

Read Full PostRead - Eye Icon
Strong Increase of Equity Trading Volumes ( 17.4%) in 2014
Finance
04/03/2015Strong Increase of Equity Trading Volumes ( 17.4%) in 2014

The World Federation of Exchanges Ltd. released its Annual Statistics Market Highlights report.

Read Full PostRead - Eye Icon
Data Warehousing: What It Is and Why It Is Important
News
25/05/2022Data Warehousing: What It Is and Why It Is Important

Cloud-based technology is rapidly changing the way people do business throughout the world. Companies can execute their operations more swiftly and effectively thanks to this technology. Important company data such as client portfolios, merchandise, and employ

Read Full PostRead - Eye Icon
How to Choose the Right Vessel for Your Business Needs
News
23/11/2023How to Choose the Right Vessel for Your Business Needs

Businesses exporting heavy-duty products or goods will have to consider the right type of cargo transportation. If goods are exported internationally, this will require consideration of the right type of vessel or ship.

Read Full PostRead - Eye Icon
Supporting the Assessment of Pandemic-Era Academics
Innovation
16/03/2022Supporting the Assessment of Pandemic-Era Academics

ExamSoft, a platform that has been lauded as the ‘Most Innovative Learning Assessment Platform’ in 2022 for the USA, has been making a difference in the academic industry by ensuring that remote examinations can be carried out in a reliable manner regardle



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow